The increased prescribing of antipsychotics, which frequently cause a brain injury that manifests as tardive dyskinesia, has provided pharmaceutical companies with a lucrative new market opportunity.
The Mad Pride movement continues to spread around the world, with a first-ever march in Mexico City.
As the novel coronavirus continues to wreak havoc around the globe, whistleblowers at American psychiatric facilities paint a picture of mismanaged COVID-19 responses and lax safety protocols, putting patients, workers, and the surrounding communities in harm’s way. Some even allege coverups of deaths.
At the Hurdalsjøen Recovery Center in Norway, patients with a long history of psychiatric hospitalizations are tapering from their medications and, in a therapeutic environment that emphasizes a good diet, exercise, and asking patients "what do they want in life," are leaving their old lives as chronic patients behind.
In 2008, a reviewer of psychiatric drugs at the FDA, Ron Kavanagh, complained to Congress that the FDA was approving a new antipsychotic that was ineffective and yet had adverse effects that increased the risk of death. Twelve years later, a review of the whistleblower documents reveal an FDA approval process that can lead to the marketing of drugs sure to harm public health.
During the past twenty years, the American Foundation for Suicide Prevention and American psychiatry have adopted a "medicalized" approach to preventing suicide, claiming that antidepressants are protective against suicide. Yet, the suicide rate in the United States has increased 30% since 2000, a time of rising usage of antidepressants. A review of studies of the effects of mental health treatment and antidepressants on suicide reveals why this medicalized approach has not only failed, but pushed suicide rates higher.
Hundreds of people have been given remote control deep brain stimulation implants for psychiatric disorders such as depression, OCD and Tourette’s. Yet DBS specialists still have no clue about its mechanisms of action and research suggests its hefty health and safety risks far outweigh benefits.
For the past 15 years, the VA's suicide prevention efforts have focused on getting veterans screened and treated for psychiatric disorders, with antidepressants a first-line therapy. This effort has caused veteran suicide rates to steadily rise.
Part one of a two-part Mad In America investigation into the expansion of psychological screening and electronic surveillance of children and youth. A new government-funded mental health training program for British Columbia family physicians and school staff promotes screening for mental disorders in all children and youth. Critics say the program omits key scientific evidence, seems more like drug promotion than medical education, and downplays serious potential harms. Nevertheless, programs like it are rolling out across Canada and the US.
"Queer Eye" has a fresh, therapeutic twist: Installment after installment, it sends the repeated messages: Take care of yourself. Be kind to yourself. You’re beautiful. You’re good. We love you. Love yourself. Or, in the words of Van Ness: Yass, queen!
A new mental health documentary awakens longstanding tensions around voice, representation, and the power to define problems and solutions.
Legal and practical barriers to voting disenfranchise people judged "mentally incompetent." The centuries-old, unclear laws and regulations also disproportionately affect people of color.
Through my research and experiences, I've found that what the Veterans Administration has been doing to fight the veteran suicide epidemic isn't working and appears to be unintentionally exacerbating it. These problems are fixable. But I need your help.
The Law Project for Psychiatric Rights is eager to provide advice or assistance to US citizens who may wish to sue their physicians for prescribing off-label psychiatric drugs to children, said lawyer James Gottstein in an interview with Mad In America.
In the past five years, there has been a dramatic explosion of interest in the Open Dialogue Therapy practiced in Tornio, Finland. It is a humanistic “treatment” that has produced five-year outcomes for psychotic patients that are, by far, the best in the developed world, and there are now groups in the United States, Europe and beyond that are seeking to “import” this care. However, the challenges for doing so are many and, last month, Open Dialogue UK - on the occasion of the first-ever fully recognized Open Dialogue training outside of Tornio - organized a conference in London to hold an open dialogue about Open Dialogue.
This week on MIA Radio, we present the second part of our podcast to join in the events for World Benzodiazepine Awareness Day 2020...
The proponents of compulsory outpatient treatment claim that it leads to better outcomes for the recipients, and protects society from violent acts by the "seriously mentally ill." Those claims are belied by history, science, and a critical review of the relevant research.
Connection, whether one-on-one or in groups, is at the heart of peer support. In a time when social distancing and stay-at-home orders proliferate, the Western Massachusetts Recovery Learning Community/Wildflower Alliance (WMRLC) is finding creative ways to adapt to rapidly changing circumstances dictated by the novel coronavirus.
The published report of the Broaden Trial of Deep Brain Stimulation for Depression whitewashed the results: although the efficacy results were negative, the investigators concluded that the therapy still showed "promise", and adverse events suffered by the patients were downplayed or attributed to the disease, and not the treatment. An in-depth investigation of how the trial results were spun, and interviews with patients that tell of harm done.
The American Psychiatric Association and its former president, Jeffrey Lieberman, have used the Goldwater Rule to try to silence Yale psychiatrist Bandy Lee and colleagues who warned, in a collection of essays, about why President Trump is "dangerous." Why would a guild choose to do this?
While the developers are promoting the apps as a public health initiative, they are effectively an AI that would be snooping on you at all times—ostensibly coming to know you better than you know yourself. And ultimately doing so for commercial purposes that will expand the psychiatric enterprise.
Disability Rights California will challenge Los Angeles’ Assisted Outpatient Treatment program in court this fall, DRC attorney Pamela Cohen announced Friday. According to Cohen, California’s AB-1241 or “Laura’s Law” diverts funding from community mental health services and towards police, administrators and courts, doesn’t reach the people it purports to be trying to help, and violates people’s civil rights. “This is an illegal program,” said Cohen.
The International Society for Ethical Psychology and Psychiatry had the clout to draw a stellar line-up of presenters to its recent conference, including internationally prominent critics like David Healy, Peter Gøtzsche, Robert Whitaker and Allen Frances. There were lots of learnings and even some tense discussions, but one of the most intriguing aspects of the entire conference was the way in which scientific and social issues became deeply intertwined, especially when presenters reached for better pathways forward.
The ACE study tells of how adverse childhood experiences increase the risk of psychological and physical problems in adulthood. When will we start incorporating these findings into public health policy and medical care?
When Carina Håkansson sent out an invitation for a symposium on "Pharmaceuticals: Risks and Alternatives," some of the world's top scientists, along with experts-by-experience, came from 13 countries to explore better ways to respond to people in crisis.
12Page 1 of 2